Hotgen Biotech Co.,Ltd was founded in 2005 and located in Biomedical Base of Zhongguancun High-Tech Park in Beijing. It is a national-level high-tech company dedicated to the development and manufacturing of innovative in-vitro diagnostic (IVD), point-of-care-testing (POCT) and biodefense products. We are one of the top 100 rapidly expansive national high-tech companies and one of the 100 fastest growing companies in Zhongguancun, which is dubbed as China’s Silicon Valley. In return for its decade-long efforts and achievements, Hotgen obtained National Award for Progress in Science and Technology in 2013, China Award for Achievements in Medical Technologies in 2012.
With its achievements and research capabilities being widely recognized, Hotgen Biotech has undertaken several provincial and national level research projects including National 863 Project, National Science Fund Project, Key Hard-Nut Tackling Project of Ministry of Science and Technology, Innovation Fund Project of Ministry of Science and Technology for Small and Median Sized Enterprises, etc.. With several products awarded as National Key Innovative Products, Hotgen Biotech was chosen as the partner of Beijing Municipality to co-build the Biodefense and POCT Key Laboratory of Beijing in 2014.
With 20 patents in hand, Hotgen Biotech has a thorough understanding of Up-converting Phosphor Technology(UPT) and is the only company in the world that utilizes UPT for the rapid diagnostic purpose and thus leads the world in UPT research, application, manufacturing and marketing of products based on UPT.
Hotgen Biotech has vastly expanded its product portfolio during the past decade from only one product at the beginning. Currently IVD products of Hotgen Biotech include instruments and kits for aiding diagnosis in cardiovascular diseases, chronic liver diseases, tumor screening and risk stratification, kidney injury, rheumatoid arthritis, infection, infectious diseases and risk assessment of preterm labor with the UPTquik® line of POCT kits based on UPT being especially popular among the customers.
The Hotgen biodefense and food safety product line covers almost all bioterrorist agents including Yersinia pestis, Anthrax, Brucella, Ricin, Abrin, etc. and all major food borne pathogenic bacteria such as cholera, E. coli, salmonella, etc.. The biodefense products have been widely used for military anti-bioterrorism campaign, customs inspection and quarantine, on-site inspection in centers for disease control, mobile bio-emergency inspection, on-site detection of food-borne pathogenic microorganisms, etc..
Over the years Hotgen Biotech has established a sales and servicing network covering all parts of China and expanding rapidly into the world. As an ISO13485 certified company with major products bearing CE mark, Hotgen Biotech has been awarded as a Beijing model company of high-standard quality control system.
Global Leader in POCT
Now after just ten years, Hotgen Biotech has become a leader in Point-of-Care-Testing (POCT) and in vitro diagnostic industry in China with a comprehensive diagnostic product portfolio covering cardio-cerebrovascular diseases, inflammation biomarkers, infectious diseases, hepatic and other carcinoma markers, liver fibrosis, kidney disease, rheumatoid diseases, preterm delivery, as well as biosecurity and food safety, drugs of abuse, etc..
We lead the global IVD industry with a group of highly innovative products:
UPTquik® – the only POCT system that combines Up-converting Phosphor Technology (UPT) and immunochromatography to quantitatively measure the concentration of target analytes in blood, serum, plasma and other specimens.
Using the unique and chemically stable lanthanide-doped inorganic phosphors as reporters that up-converts the infrared excitation source to visible and readily detectable light, UPT is the next generation of clinical diagnostic technology that features high sensitivity, rapidity, simplicity and accuracy when combined with immunochromatography.
We provide the world’s only commercially available golgi protein 73 (GP73, a new-found highly sensitive and specific hepatocellular carcinoma marker) kit both in UPT and ELISA technology.
We manufacture the world’s only or leading quantitative POCT kits including fFN(fetal Fibronection, a biomarker for preterm delivery), Lp-PLA2(Lipoprotein Associated Phospholipase A2, a new-found indicator of increasing risk of developing coronary heart disease and stroke), H-FABP(Heart-type Fatty Acid Binding Protein, a new early cardiac infarction marker), and NT-proBNP, procalcitonin, IL-6, CRP, NGAL, etc..
And we are the globally leading provider of rapid and quantitative bioterrorism detection solution covering all major bioterrorist agents like Yersinia pestis, Anthrax, Brucella, ricin, Abrin, etc..
